Distracted driving

Texting, other distractions could cost you your life

The majority of car crashes involve drivers who were distracted in the seconds leading up to the accident. In Kentucky alone, distracted driving caused 58,000 collisions in 2015. Not surprisingly, younger drivers under the age of 20 are most likely to be responsible for accidents stemming from distracted driving.

There are three main types of driving distractions:

  • Visual distractions, which occur when you take your eyes off the road.
  • Manual distractions, which occur when you your hands off the wheel
  • Cognitive distractions, which occur when you take your mind off what you’re doing.

Although all distractions can endanger a driver’s safety, texting is the most alarming because it involves all three types of distractions.

Since 2015, Kentucky has banned drivers under 18 from using cellphones – including hands-free devices – while the vehicle is in motion. Drivers of all ages are prohibited from texting while on the road.

If you are 18 or older, use good judgment if talking on a cellphone while driving. Tell the caller you may have to end the conversation. Follow these guidelines:

  • Position your phone within easy reach.
  • Dial numbers while you are not moving.
  • Do not engage in stressful or emotional conversations while driving.

Be aware that cellphones are not the only culprits in distracted driving. Other causes include:

  • Reaching for an object.
  • Using music controls.
  • Talking or listening to passengers.
  • Reading and/or writing.
  • Eating, drinking or smoking.
  • Grooming.
  • Children and pets.

Next steps:

Chefs in Action

Chefs In Action teaches healthy cooking techniques

When UK HealthCare opened its state-of-the-art dining facility, Chandler Dining, last year, it embraced the concept that food service should be as involved in teaching healthy habits as medical and nursing staff.

The long lines of institutional steamers and shelving to slide plastic trays along were gone, replaced instead with cooking hubs where diners can choose nutritious, freshly prepared food ingredients and have their dish prepared to order before their eyes.

The new facility, which is open to patients, families, staff and the public, offers restaurant-quality food selections that you wouldn’t expect to see in a hospital cafeteria.

Perhaps less expected was a teaching kitchen where chefs can demonstrate healthy meal preparations. UK HealthCare Executive Chef Pete Combs was tasked with creating a platform for sharing with hospital patients, visitors and staff the tips and techniques that make food more nutritious. The result? A monthly series called Chefs in Action.

“Chefs in Action is designed to help people see that it’s not difficult to cook healthy dishes with high-quality ingredients,” said Combs, a food service industry veteran of more than 30 years. “The power of food [in improving health] is huge.”

At 4 p.m. on the third Thursday of every month, Combs and sous chefs Justin Clark and Sarah Null prepare a themed menu with an extra dash of theater and humor. At the February event, the Heart Month-themed menu included:

  • Flaxseed hummus with almond crackers, jicama, rainbow peppers and carrot.
  • Three-bean salsa with avocado, tomato and cucumber chips.
  • Roasted butternut squash boat with asparagus, ginger, almond and wild mushrooms.
  • Rainbow trout stuffed with Fuji apples, walnuts, spinach and raisins with orange saffron sauce.
  • Raspberry banana and dark chocolate bites.

As they demonstrated each recipe and distributed free samples to the audience, dietitians Andrea Francis, Jill Haeberlin and Katie Lewis listed the ingredients in each dish and explained how they boosted heart health.

“Sharing nutrition information is as important as showing people how to make the recipe,” Combs said. “People may not want to make the apple-walnut stuffing, but they might add walnuts to one of their favorite dishes once they learn that walnuts can reduce cardiovascular problems and Type 2 diabetes.”

Housley says the long-term goal for Chefs in Action is to make the demos available to patients via the Get Well Network, an in-room patient engagement system that helps improve the transition of care from hospital to home.

“UK HealthCare is not just about medicine,” said J.J. Housley, UK HealthCare’s director of enterprise operations. “This enterprise strives to provide Kentuckians with the tools for healthy living, and why wouldn’t our food service be a significant player in that effort?”

The next Chefs in Action will be at 4 p.m., this Thursday, April 20.  The menu will center on healthy twists to Kentucky’s classic dishes. No reservations are necessary and the event is free. Check out the video below to learn more about Chefs in Action.


Next steps:

Researchers and health policy leaders from UK discussed how to combat drug abuse during this year's National Rx Drug Abuse and Heroin Summit.

UK brings expertise to national summit on opioid drug crisis

Addiction researchers, clinicians, intervention coordinators and health policy leaders from UK and UK HealthCare are taking part in a national conversation this week focused on combating the opioid drug crisis.

The National Rx Drug Abuse and Heroin Summit, taking place April 17-20 in Atlanta, is the largest national collaboration of professionals from local, state and federal agencies, business, academia, treatment providers, and allied communities impacted by prescription drug abuse and heroin use. It was introduced in 2012 under the leadership of Operation UNITE and U.S. Rep. Harold “Hal” Rogers (KY-5th) with the purpose of alleviating the burden of illegal substance abuse through comprehensive approaches. In this regard, UK leads the way.

Last year alone, investigators in the UK Center on Drug and Alcohol Research received $9.6 million for projects dedicated to substance abuse and addiction. Since 2010, the National Institute on Drug Abuse has awarded more than $92 million to UK research projects. UK HealthCare is proud to support the summit through sponsorship.

“UK is uniquely positioned to confront these questions because of its multidisciplinary research endeavors, leading academic medical center and regional referral network deployed to confront the scourge of opioids. We’re committed to working in – and with – communities to help navigate the complex nature of critical policy changes and effective healthcare implementation,” UK President Eli Capilouto said.

Kentucky’s rate of opioid overdose death remains above the national average, with the Centers for Disease Control and Prevention reporting 1,273 Kentucky overdose deaths in 2015.

“The opioid epidemic is far-reaching and multifaceted, leaving a void in each family and community it scars,” Capilouto said. “Kentucky families and communities throughout Appalachia know the devastation and havoc of addiction. That’s why this question is critical to UK researchers who lead the research, healthcare and policy questions surrounding opioid abuse.”


Next steps:

Kate Zaytseva, one of four project leaders on the COBRE grant for the Center for Cancer and Metabolism, and postdoc Naser Jafari are studying the importance of an enzyme called fatty acid synthase in controlling survival and spread of colorectal cancer.

UK wins $11.2 million NIH grant to study cancer-obesity link

UK has been awarded an $11.2 million grant from the National Institutes of Health to study the link between cancer and metabolic disorders, including obesity. The prestigious award will enable UK to launch the UK Center for Cancer and Metabolism (CCM).

The Centers of Biomedical Research Excellence (COBRE) grant to study the metabolism of cancer comes from the NIH’s National Institutes of General Medical Sciences and will fund the UK Center for Cancer and Metabolism over the next five years.

Kentucky has disproportionately high incidences of both cancer and metabolic disorders – our state leads the nation in cancer deaths and is in the top 10 for highest obesity rates in the country. While scientists have long known of a direct link between obesity and cancer, the need for further research into this field is a necessity for Kentuckians.

Senate Majority Leader Mitch McConnell of Kentucky, an advocate of the 21st Century Cures Act, contacted NIH Director Francis S. Collins on behalf of UK’s grant application.

“In an effort to improve healthcare access and outcomes for my constituents, UK has long made a priority of undertaking important research specific to Kentucky and the Appalachian region,” McConnell said.

“Over the years, UK and its Markey Cancer Center have developed one of the strongest cancer research, prevention and treatment programs in the country, as demonstrated by the center’s 2013 NIH National Cancer Institute designation, which I was proud to support. I was also pleased to assist UK in securing this competitive grant to advance and strengthen this critical health research for Kentucky by enabling advanced research focusing on the development of novel therapies for cancer treatment.”

Kentucky Representative Andy Barr echoed McConnell’s sentiments, noting that support and funding for innovative cancer research remains a priority.

“The awarding of this competitive grant is a recognition of the University of Kentucky as a national leader in biomedical research,” Barr said. “I have consistently supported the National Institutes of Health because these investments not only contribute to our local communities and institutions, they will improve and even save lives by advancing new treatments and cures. I am confident the healthcare services provided by the NCI-designated Markey Cancer Center and the research done by UK scientists funded by this grant will help us to find better ways to fight cancer, which will benefit patients and families in Kentucky and around the world.”

Linking metabolism and cancer

The UK Center for Cancer and Metabolism capitalizes on highly specialized institutional strengths in cancer and advanced metabolomics tools to focus on the underlying mechanisms that link dysfunctional metabolism to cancer. Recent studies have shown that the metabolic powerhouse of cells – the mitochondria – can influence how aggressive a cancer becomes.

UK has internationally renowned experts in the field of cancer and metabolism, and new state-of-the-art technology has improved the ability to understand how metabolism impacts cancer.

“As the University for Kentucky, we are uniquely positioned to conduct this level of sophisticated research thanks to the presence of a diverse array of biomedical researchers, clinicians and our leading academic medical center,” UK President Eli Capilouto said. “Research and development is at the core of economic and human development, and it is why UK is Kentucky’s most instrumental change agent, health provider and economic engine. The progress we make offers the brightest future and best hope for Kentucky.”

The CCM will bring together highly complementary disciplinary strengths at UK in cancer, metabolism and data sciences, coupled with sophisticated metabolomics tools and advanced cancer imaging capabilities, to strengthen the university’s cancer research enterprise by providing a thematically focused multidisciplinary infrastructure dedicated to defining the role of metabolism in the development and treatment of cancer.

“Research is at the heart of any progress we hope to make in bridging health gaps in the Commonwealth,” said Lisa Cassis, UK vice president for research. “Increased funding opportunities through the 21st Century Cures Act, and in particular this COBRE focused on cancer and metabolism, will enable the university to foster the development of the next generation of scientists who will lead our efforts in translating basic research findings into promising new therapies.”

Fighting back against cancer in Kentucky

The scientific discoveries achieved through the CCM will continue to help the UK Markey Cancer Center in its mission to conquer cancer in the Commonwealth. As Markey prepares to renew its National Cancer Institute Cancer Center designation, and simultaneously compete to become a Comprehensive Cancer Center later in 2017, Markey Director Dr. Mark Evers emphasizes the need for increased cancer research funding and continuing to push for new discoveries.

“Nowhere in the country is it more important to have this level of cancer research underway,” Evers said. “Kentuckians face a unique set of health issues, but we at the UK Markey Cancer Center are distinctly positioned to help solve the problem. Being an NCI-designated cancer center means being a leader in research as well as clinical care and outreach. This funding will allow us to translate our findings into potential new therapies for cancer patients from Kentucky and beyond.”

The CCM leverages expertise with mentors and collaborators from across multiple UK centers, disciplines and departments. The multidisciplinary collaboration is indicative of the type of work ongoing at UK and UK HealthCare every day.

“This new funding is another example of the vital importance to the people of Kentucky – and this region – in having an academic medical center at the University of Kentucky,” said Dr. Michael Karpf, UK executive vice president for health affairs. “The synergy and collaboration between researchers and clinicians to further studies in cancer can only be done at a place like this, where people are working together to make a difference in the lives of patients now and for generations to come.”

Promoting collaboration

COBRE grants also use this platform to develop promising early-stage investigators with enhanced skillsets in exciting new areas of cancer research and to enhance their success in competing for NIH grant support. The grant promotes collaborative, interactive efforts among researchers with complementary backgrounds, skills and expertise.

Four junior investigators, mentored by teams of clinicians and scientists from a variety of disciplines, departments, and colleges at UK, will lead major projects investigating an aspect of cancer metabolism:

  • “Role of vitamin D in protecting against cachexia in cancer patients,” led by Travis Thomas, Department of Clinical Sciences, UK College of Health Sciences
  • “Role of serine biosynthesis pathway in breast cancer,” led by Yadi Wu, Department of Pharmacology and Nutritional Sciences, UK College of Medicine
  • “Role of RORα in breast cancer metastasis,” led by Ren Xu, Department of Pharmacology and Nutritional Sciences, UK College of Medicine
  • “Role of fatty acid synthase in colorectal cancer,” led by Kate Zaytseva, Department of Toxicology and Cancer Biology, UK College of Medicine

The CCM is co-led by program directors Daret St. Clair, professor and James Graham Brown Foundation Endowed Chair in the UK Department of Toxicology and Cancer Biology, and Peter Zhou, professor in the UK Department of Molecular and Cellular Biochemistry.

“Having the kind of environment where learning and collaboration are placed at the forefront is why we were chosen for this grant, and we hope to continue that throughout the life of this center,” St. Clair said. “It will also enable us to reach out to new and talented researchers who want to come to UK to become new project leaders and continue the work we’re doing.”


Watch the video below to learn more about the Center for Cancer and Metabolism.


Next steps:

World Voice Day

On World Voice Day, take time to celebrate your voice

JoAnna E. Sloggy, MA, CCC-SLP

Written by JoAnna Sloggy, a speech-language pathologist and singing-voice specialist at the UK Voice & Swallow Clinic.

In the U.S., 7.5 million people have trouble using their voices. We often forget the important role voice plays in our daily lives. On Sunday, April 16, World Voice Day is a time to stop and consider the importance of the human voice in every part of our daily lives. World Voice Day aims to celebrate the human voice and raise awareness for voice disorders, vocal health, vocal training and voice research.

What causes voice disorders?

Voice is created by vibration of the vocal folds, and a voice disorder occurs when the vocal folds are unable to vibrate well enough to create a clear vocal sound. A voice disorder may be caused by voice overuse or misuse, neck and throat injuries or growths, and diseases such as cancer or Parkinson’s disease. Voice adds intent, mood and meaning to the words we speak – imagine the interpersonal loss of not being able to express yourself vocally through speech or song.

Most people have experienced temporary vocal problems such as hoarseness or loss of voice due to allergies, colds or cheering too enthusiastically for your favorite team. Usually, voice returns to normal within several days. However, if a voice change lasts for longer than two weeks, the problem should be checked by your doctor.

Be sure to practice vocal hygiene

To keep your voice healthy, follow these vocal hygiene recommendations.

  1. Listen to how your voice sounds. Hoarseness or other voice changes lasting longer than two weeks should be evaluated by a voice care team, such as an otolaryngologist and a speech-language pathologist who specializes in voice disorders.
  2. Stay hydrated. Drink plenty of water to keep your vocal folds and voice box well lubricated.
  3. Quit smoking. Tobacco, nicotine, chemicals, inhaled heat and other substances can cause inflammation and swelling of the voice box and cause cancer in the mouth, nose, throat and lungs.
  4. Avoid screaming, cheering loudly or talking over loud noise. These behaviors cause damage to the vocal fold tissue and strain to the voice muscles.
  5. Limit alcohol and caffeine. These substances have a drying effect on the vocal folds.
  6. Avoid repeated throat clearing and/or coughing. These behaviors can cause vocal damage. Try sipping water and swallowing hard when you have the urge to cough or throat clear.
  7. Manage acid reflux. Stomach acid can damage the tissue of your throat and cause hoarseness and other vocal problems.
  8. Give your voice a rest when recovering from hoarseness. When your vocal folds are swollen and inflamed, there is increased risk of vocal damage. Until your voice returns to normal, avoid straining or forcing your voice.
  9. Give your voice a break. Vocal “naps” are good when your voice is tired from overuse or from talking too loudly.

You are never too young or too old to stop and check your vocal health. Making changes to improve or maintain your good voice habits will benefit your health for years to come. This World Voice Day, take time today to celebrate your voice!

This column is scheduled to run in the Lexington Herald-Leader this weekend.


Next steps:

A new study, done in part at the UK Markey Cancer Center, shed light on why lung cancer cells can resist therapeutic cancer treatment.

Markey research sheds light on lung cancer formation and treatment

A new study co-authored by a researcher starting her laboratory at the UK Markey Cancer Center shows that in certain genetic situations, one non-small cell lung cancer subtype can change into another subtype.

This lung cancer “lineage switching” could explain why some cancers are resistant to therapeutics, and this research examines exactly how the lineage switch can happen. The work was a collaborative effort between laboratories in Kentucky, New York and Boston.

“Now that we have a glimpse into the molecular mechanism of lineage switching, we can begin to learn how to manipulate this phenomenon for better therapeutic outcomes,” said study co-author Christine Fillmore Brainson, assistant professor in the UK Toxicology and Cancer Biology department.

Previously, it was unclear which cells in the adult lung can be the “cells-of-origin” of the two major subtypes of non-small cell lung cancer, namely adenocarcinoma and squamous cell carcinoma. Likewise, it was unclear what differences in DNA organization define the two distinct lung cancer subtypes. The existence of adenosquamous lung tumors, clinically defined by the presence of both glandular adenocarcinoma lesions and fully stratified squamous lesions within the same tumor, suggested that both adenocarcinomas and squamous cell carcinomas could come from the same cells in the lung, but clear evidence for this theory was lacking.

Published in Nature Communications, the study showed that adenocarcinoma cells can change to squamous cells due to reorganization of their DNA in specific ways. Beginning with a mouse model of adenosquamous lung tumors, researchers validated the genetics by comparing it to human adenosquamous lung tumor – the genetics are often the same, including activation of the oncogene KRAS and the deletion of the tumor suppressor Lkb1. The team then used transplant assays to demonstrate that established adenocarcinoma tumors could transition to squamous cell carcinomas in the mouse lung.

Lastly, the group isolated different lung cells, and demonstrated that only certain lung cells could give rise to tumors capable of undergoing the lineage switch.

“This data is exciting because it shows which cells in the lung can give rise to adenosquamous tumors,” Brainson said.  “And the technique we used to transform the isolated cells can be applied to many lung cancer models.”

Oncologists have observed this “lineage switching” after the failure of EGFR tyrosine kinase inhibitor treatment, when it is clinically justifiable to take a second biopsy. However, second biopsies are not normally done after chemotherapy, a practice that Brainson thinks could be revised to understand the exact mechanisms of therapy resistance.

In addition to Brainson, the manuscript was co-authored by Haikuo Zhang of the Dana-Farber Cancer Institute in Boston. The research was a collaborative effort between the laboratories of Carla Kim at Boston Children’s Hospital, where Brainson was based for her post-doctoral studies; Hideo Watanabe at Icahn School of Medicine in New York; and Dr. Kwok-Kin Wong at Pearlmutter Cancer Center in New York.

This work was funded in part by the American Cancer Society, the Lung Cancer Research Foundation, the V Foundation for Cancer Research, the March of Dimes, the National Cancer Institute, the Gross-Loh Family Fund for Lung Cancer Research and Susan Spooner Family Lung Cancer Research Fund at the Dana-Farber Cancer Institute


Next steps:

What you need to know about mumps

What you need to know about mumps

Last week, UK’s University Health Service saw a couple of isolated cases of mumps, a contagious virus whose tell-tale symptom is swelling near the neck and jaw.

Although the overwhelming majority of people who get mumps recover completely, it’s important to know the signs of the virus and what to do if you think you have it.

What is mumps?

Mumps is an illness caused by the mumps virus. It’s easily spread by airborne droplets from the upper respiratory tract.

Mumps typically starts with a few days of fever, headache, fatigue and loss of appetite, followed by swollen salivary glands, or swelling near the neck and jaw. Since the introduction of the mumps vaccine, cases of mumps in the U.S. are uncommon.

What are the symptoms of mumps?

Many children have no symptoms or very mild symptoms. The following are the most common symptoms of mumps that may be seen in both adults and children:

  • Discomfort in the salivary glands (in front of the ears), which may become swollen and tender.
  • Difficulty chewing.
  • Pain and tenderness of the testicles.
  • Fever.
  • Headache.
  • Muscle aches.
  • Tiredness.
  • Loss of appetite.

The symptoms of mumps may look like other conditions or medical problems. Always consult your doctor for a diagnosis.

What should you do if you think you have mumps?

  • UK students: Students who have swollen parotid salivary glands should make an appointment with UHS to be evaluated or see their family physician. Students can go online and make a clinician appointment via the Student Health Link on the LinkBlue/My UK portal or by calling 859-323-APPT (2778) Monday through Friday from 8 a.m. to 5 p.m.
  • UK faculty and staff: If you have symptoms, see your local clinician, or if you can’t get an appointment with your regular clinician and have UK HMO, PPO, or EM, you can call for an appointment at the UK Health Plans Urgent Care Clinic at 859-323-SICK (7425).
  • Non-UK employees: If you’re not a UK employee, but are experiencing symptoms, contact your primary care physician and make an appointment.

If you have any of the symptoms of mumps, avoid prolonged close contact with other people for five days after your salivary glands began to swell. You should not go to work or classes during this period.

In addition to staying away from others, you can help prevent the virus from spreading by covering your mouth and nose with a tissue when you cough or sneeze, washing hands frequently, and wearing a mask if you have to be around others.

What complications are associated with mumps?

Complications of mumps occur more frequently among adults than children, and may include:

  • Meningitis or encephalitis. Inflammation of the membrane that covers the brain and spinal cord or inflammation of the brain.
  • Orchitis. Inflammation of one or both testicles.
  • Mastitis. Inflammation of breast tissue.
  • Oophoritis. Inflammation of one or both ovaries.
  • Pancreatitis. Inflammation of the pancreas.
  • Deafness

How is mumps diagnosed?

In addition to a complete medical history and medical exam, your healthcare provider may also take a swab of the side of your mouth to confirm the diagnosis.

What is the treatment for mumps?

Treatment is usually limited to medications for pain and plenty of fluids. Sometimes bedrest is necessary the first few days. According to the CDC, adults should stay home from work for five days after glands begin to swell. Children should stay out of school until symptoms have subsided. Both adults and children with mumps symptoms should minimize contact with other people who live in their homes. Good basic hygiene practices, such as thorough hand-washing, covering the mouth when sneezing or coughing, and regularly cleaning frequently-touched surfaces, are also important in disease control.

How can mumps be prevented?

The measles, mumps and rubella (MMR) is a childhood combination vaccination against mumps, measles and rubella. The MMR provides immunity for most people. People who have had the mumps are immune for life.

If you have not previously been vaccinated or if you are unsure if you have received two doses of the MMR vaccine, we are recommending that you get vaccinated.

Usually, the first dose of the MMR vaccine is given when a child is 12 to 15 months old, and a second dose is given at 4 to 6 years of age. However, if 28 days have passed since the first dose was given, a second dose may be given before the age of 4.


Next steps:

A research study from UK and University of Indiana-Purdue University Indianapolis shows the benefits of massage therapy for lower back pain.

Got lower back pain? Massage therapy may help, says UK researcher

William G. Elder Jr., PhD

Clinical massage therapy can alleviate lower back pain according to new research published in part by William Elder, PhD, a researcher at UK Family & Community Medicine.

The results from the Kentucky Pain Research and Outcomes Study appeared in the March edition of the journal Pain Medicine. The researchers tested the effectiveness of massage therapy intervention to reduce pain and disability and improve quality of life in patients with chronic lower back pain.

Elder said the results fill in a gap of medical literature showing the real-world effects of massage therapy as an alternative to pharmacologic therapies for lower back pain.

“Our study generated convincing evidence that massage may be used as a beneficial therapy for sufferers of lower back pain,” Elder said. “With a high prevalence of lower back pain across the nation, our study responds to the need for effective complementary therapies that can be disseminated through a primary care setting.”

In the study, Kentucky primary care physicians referred patients with chronic lower back pain to a licensed community massage therapist, and study participants were evaluated after 12 weeks and after 10 massage-therapy sessions, as well as at a 24-month follow-up appointment. At 12 weeks through the intervention, 75 percent of participants experienced improvement in physical and cognitive measures. The study also showed participants experienced meaningful improvement at the 24-week mark.

In addition, the study showed that adults 49 and older benefited from massage therapy more than younger adults.

Elder collaborated with co-author Niki Munk, a licensed massage therapist and health sciences researcher at the University of Indiana-Purdue University Indianapolis. The study was recently featured on Time.com.


Next steps:

sports-related injuries

5 tips to prevent sports-related injuries in kids

Warmer weather is here and the spring sports season is just around the corner. Now’s the time to make sure your kids take the right precautions to avoid sports-related injuries.

In 2013, more than 1 million children ages 19 and under were seen in emergency departments for injuries related to 14 commonly played sports. Here are some tips to help you and your kids prevent injury:

1. Get a physical

Before playing organized sports, make sure your child receives a pre-participation physical exam, or PPE. This should be performed by a doctor or a nurse practitioner or qualified clinician under the supervision of a physician.

2. Stay hydrated

Bring a water bottle to practice and games. Encourage children to stay well-hydrated by drinking plenty of water before, during and after play.

3. Stretch

Stretching before practice and games can release muscle tension and help prevent sports-related injuries, such as muscle tears or sprains. Make sure there is time set aside before every practice and game for athletes to warm up properly.

4. Take time off

Encourage kids to take time off from one sport to prevent overuse injuries. It is an opportunity to get stronger and develop skills learned in another sport.

5. Coaches, know your stuff

It’s also a good idea for coaches to get certified in first aid and CPR, learn the signs and symptoms of a concussion, and help avoid overuse injury by resting players during practices and games.


Next steps:

Dr. Craig van Horne, director of the Deep Brain Stimulator Center at the Kentucky Neuroscience Institute, spoke about his aspirations and hidden talents.

Watch: 5 questions with neurosurgeon Dr. Craig van Horne

Neurosurgeon Dr. Craig van Horne came to Kentucky from Boston to pursue an idea: Could peripheral nerve tissue implanted in the brain reduce the symptoms of Parkinson’s disease?

Van Horne is the director of the Deep Brain Stimulator Center at the Kentucky Neuroscience Institute. He focuses his research on cellular and surgical therapies for Parkinson’s disease.

Deep brain stimulation, or DBS, is a surgical procedure that uses electrodes to stimulate areas of the brain, effectively overriding the damaged nerve’s electrical impulses and reducing many of the symptoms related to Parkinson’s disease. Van Horne is testing an experimental procedure called DBS Plus, which uses a patient’s own peripheral nerve tissue to prompt nerve regeneration and slow the disease process.

Van Horne says the teamwork and support at UK HealthCare – plus a healthy dose of Kentucky hospitality – fostered the atmosphere he needed to bring DBS Plus to fruition. (And having a lucky cap doesn’t hurt.)

Watch this episode of “Five Questions” to learn more about Dr. van Horne’s aspirations and secret talents.


Next steps: